Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Change in Net Loans (2016 - 2018)

Fortress Biotech (FBIO) has 3 years of Change in Net Loans data on record, last reported at $176000.0 in Q3 2018.

  • For Q3 2018, Change in Net Loans rose 486.67% year-over-year to $176000.0; the TTM value through Sep 2018 reached $988000.0, up 513.66%, while the annual FY2017 figure was $597000.0, 610.71% up from the prior year.
  • Change in Net Loans reached $176000.0 in Q3 2018 per FBIO's latest filing, down from $214000.0 in the prior quarter.
  • Across five years, Change in Net Loans topped out at $520000.0 in Q4 2017 and bottomed at $17000.0 in Q1 2017.
  • Average Change in Net Loans over 3 years is $143625.0, with a median of $81000.0 recorded in 2016.
  • The widest YoY moves for Change in Net Loans: up 613.33% in 2018, down 358.82% in 2018.
  • A 3-year view of Change in Net Loans shows it stood at $84000.0 in 2016, then skyrocketed by 519.05% to $520000.0 in 2017, then plummeted by 66.15% to $176000.0 in 2018.
  • Per Business Quant database, its latest 3 readings for Change in Net Loans were $176000.0 in Q3 2018, $214000.0 in Q2 2018, and $78000.0 in Q1 2018.